These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2877112)

  • 21. [Monotherapy of uncomplicated essential hypertension with metoprolol].
    Mahlke R; Kühns K
    Med Welt; 1980 Feb; 31(9):333-5. PubMed ID: 7374428
    [No Abstract]   [Full Text] [Related]  

  • 22. [Atenolol in essential arterial hypertension: clinical experience].
    Pieri R; Misceo N; Pirrelli A
    Clin Ter; 1981 May; 97(4):395-404. PubMed ID: 7018820
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dose-response study of betaxolol in arterial hypertension].
    Pathe M; Steimer C; Cazor JL; Schwartz J
    Therapie; 1983; 38(2):143-8. PubMed ID: 6356451
    [No Abstract]   [Full Text] [Related]  

  • 25. [Atenolol and metoprolol in the treatment of slight to moderate hypertension. A comparative study].
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Ugeskr Laeger; 1982 Dec; 144(51):2823-6. PubMed ID: 6762745
    [No Abstract]   [Full Text] [Related]  

  • 26. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metoprolol in the treatment of essential hypertension (author's transl)].
    Salgueiro Rodríguez M; Pérez Pombo S; Beiras García E
    Med Clin (Barc); 1981 Feb; 76(3):121-4. PubMed ID: 7206875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
    Liedholm H; Ursing D
    Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G; Sölter H
    Arzneimittelforschung; 1983; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive effect of tienilic acid prescribed individually or in combination with atenolol].
    Pauchant A; Bernard ; Martin ; Petit ; Richard
    Lille Med; 1981 Mar; 26(3):144-6. PubMed ID: 7289751
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Pisani R; Scapellato L
    Minerva Nefrol; 1982; 29(3):159-64. PubMed ID: 6292792
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of penbutolol and atenolol in the therapy of essential hypertension].
    Fallo F; Pisani G; Mantero F
    Clin Ter; 1988 Jun; 125(6):425-30. PubMed ID: 2973948
    [No Abstract]   [Full Text] [Related]  

  • 34. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
    De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E
    Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061
    [No Abstract]   [Full Text] [Related]  

  • 38. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 39. [Behavior of the hemorrheological pattern in subjects with essential hypertension treated with beta-blocking agents. I. Timolol].
    Sarno A; Ferrara F; Catania A; Frazzetta F; Capobianco D; Caimi G
    Clin Ter; 1982 Nov; 103(3):267-71. PubMed ID: 7151381
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.